Evaluation of butaperazine in chronic schizophrenia.
D000328:Adult; D002074:Butanones / Q000009:adverse effects / Q000627:therapeutic use*; D002746:Chlorpromazine / Q000009:adverse effects / Q000627:therapeutic use*; D002908:Chronic Disease; D005260:Female; D006801:Humans; D008875:Middle Aged; D010640:Phenothiazines / Q000009:adverse effects / Q000627:therapeutic use*; D010879:Piperazines / Q000009:adverse effects / Q000627:therapeutic use*; D010919:Placebos; D011581:Psychological Tests; D012559:Schizophrenia / Q000188:drug therapy*; D014149:Tranquilizing Agents / Q000009:adverse effects / Q000627:therapeutic use*
D002074:Butanones; D010640:Phenothiazines; D010879:Piperazines; D010919:Placebos; D014149:Tranquilizing Agents; D002746:Chlorpromazine